Breadcrumb

CTB News

Marcel Behr appointed interim director McGill Interdisciplinary Initiative in Infection and Immunity

Founding director Don Sheppard to direct Antimicrobial Resistance Task Force at the Public Health Agency...

Unraveling the complexity of vitamin B12 diseases

Nature Communications study has implications for treatment of patients and genetic counselling

RI-MUHC researchers led one of Québec Science magazine’s top 10 discoveries of the year

Jean-Jacques Lebrun and his team have discovered a promising treatment for triple negative breast cancer

Three RI-MUHC research projects funded in special CIHR calls

Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence

$2M to the MUHC Foundation for precision cancer care

BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program

McGill team’s index predicts coma recovery with 100% accuracy

New Adaptive Reconfiguration Index has crucial implications for clinical management and decision-making in unconscious and unresponsive...

FANCI: a new gene at the origin of some cases of ovarian cancer

For the first time, researchers link mutations in the FANCI gene to the risk of developing ovarian cancer

RI-MUHC trainee Prisca Bustamante honoured by Mitacs Award for Outstanding Innovation

Doctoral student develops world's first non-invasive blood screening test for uveal melanoma

Adel Schwertani is corecipient of the sixth Tomoh Masaki Award

RI-MUHC scientist receives international acclaim for research that benefits pulmonary arterial hypertension patients

RI-MUHC study shows impact of combinatorial immunotherapy on an aggressive cancer

A combinatorial immunotherapy may provide significant therapeutic benefit in managing pancreatic ductal...

Explore news and events at the RI-MUHC